GRCE: FY:25 Second Quarter Results
Grace is a clinical-stage, biotechnology company focused on rare disease. Its lead program, GTX-104, is a novel injectable formulation of...
Grace Therapeutics, Inc: Initiating Coverage – From Confusion to Infusion
Grace is a clinical-stage, biotechnology company focused on rare disease.Its lead program is for GTX-104, a novel injectable formulation of...
No more insights